Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Mesenchymal Stem Cell Extracellular Vesicles Reverse Sugen/Hypoxia Pulmonary Hypertension in Rats.

Klinger JR, Pereira M, Del Tatto M, Brodsky AS, Wu KQ, Dooner MS, Borgovan T, Wen S, Goldberg LR, Aliotta JM, Ventetuolo CE, Quesenberry PJ, Liang OD.

Am J Respir Cell Mol Biol. 2019 Nov 13. doi: 10.1165/rcmb.2019-0154OC. [Epub ahead of print]

PMID:
31721618
2.

Biodistribution of Mesenchymal Stem Cell-Derived Extracellular Vesicles in a Radiation Injury Bone Marrow Murine Model.

Wen S, Dooner M, Papa E, Del Tatto M, Pereira M, Borgovan T, Cheng Y, Goldberg L, Liang O, Camussi G, Quesenberry P.

Int J Mol Sci. 2019 Nov 2;20(21). pii: E5468. doi: 10.3390/ijms20215468.

3.

Lipid phosphatase SHIP-1 regulates chondrocyte hypertrophy and skeletal development.

So EY, Sun C, Wu KQ, Driesman A, Leggett S, Isaac M, Spangler T, Dubielecka-Szczerba PM, Reginato AM, Liang OD.

J Cell Physiol. 2020 Feb;235(2):1425-1437. doi: 10.1002/jcp.29063. Epub 2019 Jul 9.

4.

Prevalence and Effect on Survival of Pulmonary Hypertension in Myelofibrosis.

Austin M, Quesenberry PJ, Ventetuolo CE, Liang O, Reagan JL.

Clin Lymphoma Myeloma Leuk. 2019 Sep;19(9):593-597. doi: 10.1016/j.clml.2019.05.009. Epub 2019 May 13.

PMID:
31262666
5.

Low dose 100 cGy irradiation as a potential therapy for pulmonary hypertension.

Egan PC, Liang OD, Goldberg LR, Aliotta JM, Pereira M, Borgovan T, Dooner M, Camussi G, Klinger JR, Quesenberry PJ.

J Cell Physiol. 2019 Nov;234(11):21193-21198. doi: 10.1002/jcp.28723. Epub 2019 Apr 22.

6.

Loss of lipid phosphatase SHIP1 promotes macrophage differentiation through suppression of dendritic cell differentiation.

So EY, Sun C, Reginato AM, Dubielecka PM, Ouchi T, Liang OD.

Cancer Biol Ther. 2019;20(2):201-211. doi: 10.1080/15384047.2018.1523846. Epub 2018 Oct 2.

7.

Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling human myelofibrosis.

Chorzalska A, Morgan J, Ahsan N, Treaba DO, Olszewski AJ, Petersen M, Kingston N, Cheng Y, Lombardo K, Schorl C, Yu X, Zini R, Pacilli A, Tepper A, Coburn J, Hryniewicz-Jankowska A, Zhao TC, Oancea E, Reagan JL, Liang O, Kotula L, Quesenberry PJ, Gruppuso PA, Manfredini R, Vannucchi AM, Dubielecka PM.

Blood. 2018 Nov 8;132(19):2053-2066. doi: 10.1182/blood-2018-05-848408. Epub 2018 Sep 13.

8.

Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemia.

Chorzalska A, Ahsan N, Rao RSP, Roder K, Yu X, Morgan J, Tepper A, Hines S, Zhang P, Treaba DO, Zhao TC, Olszewski AJ, Reagan JL, Liang O, Gruppuso PA, Dubielecka PM.

Mol Oncol. 2018 May;12(5):630-647. doi: 10.1002/1878-0261.12186. Epub 2018 Apr 6.

9.

Endothelial to haematopoietic transition contributes to pulmonary arterial hypertension.

Liang OD, So EY, Egan PC, Goldberg LR, Aliotta JM, Wu KQ, Dubielecka PM, Ventetuolo CE, Reginato AM, Quesenberry PJ, Klinger JR.

Cardiovasc Res. 2017 Nov 1;113(13):1560-1573. doi: 10.1093/cvr/cvx161.

10.

M1 Macrophage-Induced Endothelial-to-Mesenchymal Transition Promotes Infantile Hemangioma Regression.

Wu KQ, Muratore CS, So EY, Sun C, Dubielecka PM, Reginato AM, Liang OD.

Am J Pathol. 2017 Sep;187(9):2102-2111. doi: 10.1016/j.ajpath.2017.05.014. Epub 2017 Jul 12.

11.

Bone Marrow Endothelial Progenitor Cells Are the Cellular Mediators of Pulmonary Hypertension in the Murine Monocrotaline Injury Model.

Aliotta JM, Pereira M, Wen S, Dooner MS, Del Tatto M, Papa E, Cheng Y, Goldberg L, Ventetuolo CE, Liang O, Klinger JR, Quesenberry PJ.

Stem Cells Transl Med. 2017 Jul;6(7):1595-1606. doi: 10.1002/sctm.16-0386. Epub 2017 May 5.

12.

Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia.

Chorzalska A, Kim JF, Roder K, Tepper A, Ahsan N, Rao RSP, Olszewski AJ, Yu X, Terentyev D, Morgan J, Treaba DO, Zhao TC, Liang O, Gruppuso PA, Dubielecka PM.

Stem Cells Dev. 2017 May 1;26(9):656-677. doi: 10.1089/scd.2016.0262. Epub 2017 Feb 27.

13.

Apyrase as a novel therapeutic inhibitor of heterotopic ossification.

Liang OD, Reginato AM, Medici D.

Ann Transl Med. 2015 May;3(Suppl 1):S32. doi: 10.3978/j.issn.2305-5839.2015.03.45. No abstract available.

14.

Bone marrow-derived multipotent stromal cells attenuate inflammation in obliterative airway disease in mouse tracheal allografts.

Casey A, Dirks F, Liang OD, Harrach H, Schuette-Nuetgen K, Leeman K, Kim CF, Gerard C, Subramaniam M.

Stem Cells Int. 2014;2014:468927. doi: 10.1155/2014/468927. Epub 2014 Sep 10.

15.

Deficiency of lipid phosphatase SHIP enables long-term reconstitution of hematopoietic inductive bone marrow microenvironment.

Liang OD, Lu J, Nombela-Arrieta C, Zhong J, Zhao L, Pivarnik G, Mondal S, Chai L, Silberstein LE, Luo HR.

Dev Cell. 2013 May 28;25(4):333-49. doi: 10.1016/j.devcel.2013.04.016.

16.

Green tea epigallo-catechin-galleate ameliorates the development of obliterative airway disease.

Liang OD, Kleibrink BE, Schuette-Nuetgen K, Khatwa UU, Mfarrej B, Subramaniam M.

Exp Lung Res. 2011 Sep;37(7):435-44. doi: 10.3109/01902148.2011.584359. Epub 2011 Jul 25.

17.

Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension.

Vergadi E, Chang MS, Lee C, Liang OD, Liu X, Fernandez-Gonzalez A, Mitsialis SA, Kourembanas S.

Circulation. 2011 May 10;123(18):1986-95. doi: 10.1161/CIRCULATIONAHA.110.978627. Epub 2011 Apr 25.

18.

Mesenchymal stromal cells expressing heme oxygenase-1 reverse pulmonary hypertension.

Liang OD, Mitsialis SA, Chang MS, Vergadi E, Lee C, Aslam M, Fernandez-Gonzalez A, Liu X, Baveja R, Kourembanas S.

Stem Cells. 2011 Jan;29(1):99-107. doi: 10.1002/stem.548.

19.

Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease.

Aslam M, Baveja R, Liang OD, Fernandez-Gonzalez A, Lee C, Mitsialis SA, Kourembanas S.

Am J Respir Crit Care Med. 2009 Dec 1;180(11):1122-30. doi: 10.1164/rccm.200902-0242OC. Epub 2009 Aug 27.

20.

Divergent cardiopulmonary actions of heme oxygenase enzymatic products in chronic hypoxia.

Vitali SH, Mitsialis SA, Liang OD, Liu X, Fernandez-Gonzalez A, Christou H, Wu X, McGowan FX, Kourembanas S.

PLoS One. 2009 Jun 19;4(6):e5978. doi: 10.1371/journal.pone.0005978.

Supplemental Content

Loading ...
Support Center